Trial Profile
The effect of sitagliptin on circadian rhythm in blood glucose using CGM (continuous glucose monitoring) in the elderly patients with diabetes
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 04 Nov 2017
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 02 Nov 2017 Status changed from recruiting to discontinued.
- 12 Nov 2013 New trial record